FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3209209610> ?p ?o ?g. }

• W3209209610 endingPage "154" @default.
• W3209209610 startingPage "143" @default.
• W3209209610 abstract "Intrinsic molecular subtypes may explain marked variation between bladder cancer patients in prognosis and response to therapy. Complex testing algorithms and little attention to more prevalent, early-stage (non-muscle invasive) bladder cancers (NMIBCs) have hindered implementation of subtyping in clinical practice. Here, using a three-antibody immunohistochemistry (IHC) algorithm, we identify the diagnostic and prognostic associations of well-validated proteomic features of basal and luminal subtypes in NMIBC. By IHC, we divided 481 NMIBCs into basal (GATA3- /KRT5+ ) and luminal (GATA3+ /KRT5 variable) subtypes. We further divided the luminal subtype into URO (p16 low), URO-KRT5+ (KRT5+ ), and genomically unstable (GU) (p16 high) subtypes. Expression thresholds were confirmed using unsupervised hierarchical clustering. Subtypes were correlated with pathology and outcomes. All NMIBC cases clustered into the basal/squamous (basal) or one of the three luminal (URO, URO-KRT5+ , and GU) subtypes. Although uncommon in this NMIBC cohort, basal tumors (3%, n = 16) had dramatically higher grade (100%, n = 16, odds ratio [OR] = 13, relative risk = 3.25) and stage, and rapid progression to muscle invasion (median progression-free survival = 35.4 months, p = 0.0001). URO, the most common subtype (46%, n = 220), showed rapid recurrence (median recurrence-free survival [RFS] = 11.5 months, p = 0.039) compared to its GU counterpart (29%, n = 137, median RFS = 16.9 months), even in patients who received intravesical immunotherapy (p = 0.049). URO-KRT5+ tumors (22%, n = 108) were typically low grade (66%, n = 71, OR = 3.7) and recurred slowly (median RFS = 38.7 months). Therefore, a simple immunohistochemical algorithm can identify clinically relevant molecular subtypes of NMIBC. In routine clinical practice, this three-antibody algorithm may help clarify diagnostic dilemmas and optimize surveillance and treatment strategies for patients." @default.
• W3209209610 created "2021-11-08" @default.
• W3209209610 creator A5012860810 @default.
• W3209209610 creator A5021590658 @default.
• W3209209610 creator A5030341447 @default.
• W3209209610 creator A5042249219 @default.
• W3209209610 creator A5050632344 @default.
• W3209209610 creator A5052525388 @default.
• W3209209610 creator A5058902093 @default.
• W3209209610 creator A5066260723 @default.
• W3209209610 creator A5075804863 @default.
• W3209209610 creator A5088442918 @default.
• W3209209610 creator A5089143676 @default.
• W3209209610 date "2021-10-26" @default.
• W3209209610 modified "2023-10-12" @default.
• W3209209610 title "Diagnostic and prognostic implications of a three‐antibody molecular subtyping algorithm for non‐muscle invasive bladder cancer" @default.
• W3209209610 cites W1530437552 @default.
• W3209209610 cites W1572827793 @default.
• W3209209610 cites W1978489551 @default.
• W3209209610 cites W2000357107 @default.
• W3209209610 cites W2008958654 @default.
• W3209209610 cites W2020523946 @default.
• W3209209610 cites W2022598724 @default.
• W3209209610 cites W2033775272 @default.
• W3209209610 cites W2034652735 @default.
• W3209209610 cites W2056297380 @default.
• W3209209610 cites W2067964015 @default.
• W3209209610 cites W2079542321 @default.
• W3209209610 cites W2093673484 @default.
• W3209209610 cites W2104339108 @default.
• W3209209610 cites W2114124411 @default.
• W3209209610 cites W2124614719 @default.
• W3209209610 cites W2135231064 @default.
• W3209209610 cites W2142655452 @default.
• W3209209610 cites W2157153728 @default.
• W3209209610 cites W2164263233 @default.
• W3209209610 cites W2340189072 @default.
• W3209209610 cites W2426844253 @default.
• W3209209610 cites W2443056117 @default.
• W3209209610 cites W2509266256 @default.
• W3209209610 cites W2531814188 @default.
• W3209209610 cites W2560018230 @default.
• W3209209610 cites W2570895624 @default.
• W3209209610 cites W2588621824 @default.
• W3209209610 cites W2591099423 @default.
• W3209209610 cites W2604535399 @default.
• W3209209610 cites W2609464379 @default.
• W3209209610 cites W2621022579 @default.
• W3209209610 cites W2755292546 @default.
• W3209209610 cites W2763670669 @default.
• W3209209610 cites W2785803176 @default.
• W3209209610 cites W2791111208 @default.
• W3209209610 cites W2801480908 @default.
• W3209209610 cites W2890512043 @default.
• W3209209610 cites W2908453839 @default.
• W3209209610 cites W2916183155 @default.
• W3209209610 cites W2953107254 @default.
• W3209209610 cites W2953442466 @default.
• W3209209610 cites W2954655827 @default.
• W3209209610 cites W2960850092 @default.
• W3209209610 cites W2975497362 @default.
• W3209209610 cites W2981018914 @default.
• W3209209610 cites W3035746651 @default.
• W3209209610 cites W3043805529 @default.
• W3209209610 cites W3153221280 @default.
• W3209209610 cites W316269977 @default.
• W3209209610 doi "https://doi.org/10.1002/cjp2.245" @default.
• W3209209610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34697907" @default.
• W3209209610 hasPublicationYear "2021" @default.
• W3209209610 type Work @default.
• W3209209610 sameAs 3209209610 @default.
• W3209209610 citedByCount "8" @default.
• W3209209610 countsByYear W32092096102022 @default.
• W3209209610 countsByYear W32092096102023 @default.
• W3209209610 crossrefType "journal-article" @default.
• W3209209610 hasAuthorship W3209209610A5012860810 @default.
• W3209209610 hasAuthorship W3209209610A5021590658 @default.
• W3209209610 hasAuthorship W3209209610A5030341447 @default.
• W3209209610 hasAuthorship W3209209610A5042249219 @default.
• W3209209610 hasAuthorship W3209209610A5050632344 @default.
• W3209209610 hasAuthorship W3209209610A5052525388 @default.
• W3209209610 hasAuthorship W3209209610A5058902093 @default.
• W3209209610 hasAuthorship W3209209610A5066260723 @default.
• W3209209610 hasAuthorship W3209209610A5075804863 @default.
• W3209209610 hasAuthorship W3209209610A5088442918 @default.
• W3209209610 hasAuthorship W3209209610A5089143676 @default.
• W3209209610 hasBestOaLocation W32092096101 @default.
• W3209209610 hasConcept C102037460 @default.
• W3209209610 hasConcept C104317684 @default.
• W3209209610 hasConcept C11413529 @default.
• W3209209610 hasConcept C121608353 @default.
• W3209209610 hasConcept C126322002 @default.
• W3209209610 hasConcept C142724271 @default.
• W3209209610 hasConcept C143998085 @default.
• W3209209610 hasConcept C199360897 @default.
• W3209209610 hasConcept C204232928 @default.
• W3209209610 hasConcept C2778024521 @default.
• W3209209610 hasConcept C2779306644 @default.

• next